How does opioid potency compare across different medications. What factors influence the relative strength of various opioids. Which opioids are considered the strongest and weakest on the narcotic strength scale. How can understanding opioid equivalence help prevent overdose risks.

Understanding the Opioid Potency Scale

The opioid potency scale, also known as the narcotic strength scale, provides a crucial framework for comparing the relative strength of different opioid medications. This scale is essential for healthcare professionals, patients, and researchers to understand the comparative effects and dosing requirements of various opioids.

To comprehend the opioid potency scale, it’s important to recognize that it’s not a simple linear ranking. Instead, it’s a complex comparison that takes into account multiple factors:

• Analgesic effect (pain-relieving power)
• Dose required for equivalent pain relief
• Route of administration (oral, intravenous, etc.)
• Duration of action
• Metabolism and elimination rates

The scale typically uses morphine as a reference point, with other opioids’ potencies expressed relative to morphine. This allows for a standardized comparison across different medications.

Key Factors Influencing Opioid Potency

Several critical factors contribute to the overall potency of an opioid:

1. Receptor Affinity

Opioids work by binding to specific receptors in the brain and nervous system. The strength of this binding, known as receptor affinity, plays a significant role in potency. Opioids with higher receptor affinity tend to be more potent.

2. Lipid Solubility

The ability of an opioid to cross the blood-brain barrier affects its potency. Opioids with higher lipid solubility can more easily enter the central nervous system, potentially increasing their potency.

3. Metabolism and Half-life

How quickly the body processes and eliminates an opioid influences its duration of action and overall potency. Opioids with longer half-lives may have more prolonged effects.

4. Route of Administration

The method by which an opioid is administered can significantly impact its potency. For example, intravenous administration often results in higher potency compared to oral administration due to increased bioavailability.

Comparing Opioid Strengths: The Equivalence Chart

The opioid equivalence chart provides a valuable tool for comparing the relative strengths of different opioids. Based on the World Health Organization (WHO) Guidelines, here’s an overview of approximate potencies relative to morphine:

It’s crucial to note that these ratios are approximate and can vary based on individual factors and specific formulations.

Strongest Opioids: Potent Pain Relief and High Risks

At the upper end of the opioid potency scale, we find some of the most powerful pain relievers available in medical practice. These opioids offer intense analgesic effects but also come with significant risks of dependence and overdose.

Fentanyl: The Synthetic Powerhouse

Fentanyl stands out as one of the most potent opioids, with a potency 50-100 times that of morphine. Originally developed for severe pain management in cancer patients, fentanyl’s high potency makes it both a valuable medical tool and a dangerous substance when misused.

Carfentanil: The Elephant Tranquilizer

Although not typically used in human medicine, carfentanil deserves mention as one of the most potent opioids known. With a potency approximately 10,000 times that of morphine, it’s primarily used as a large animal tranquilizer. Its presence in illicit drug supplies has led to numerous overdose deaths.

Sufentanil and Remifentanil

These synthetic opioids, like fentanyl, are extremely potent. Sufentanil is about 5-10 times more potent than fentanyl, while remifentanil is similar in strength to fentanyl but has a very short duration of action, making it useful for certain medical procedures.

Moderate Strength Opioids: Balancing Efficacy and Safety

In the middle range of the opioid potency scale, we find medications that offer significant pain relief while potentially having a somewhat lower risk profile compared to the strongest opioids.

Oxycodone

Oxycodone is approximately 1.5 times more potent than morphine. It’s widely used for moderate to severe pain and is available in both immediate-release and extended-release formulations.

Hydromorphone

Also known by the brand name Dilaudid, hydromorphone is about 5 times more potent than morphine. It’s often used for severe pain, particularly in hospital settings.

Methadone

While methadone’s potency can vary widely depending on the dosing regimen, it’s generally considered to be equipotent to morphine for single doses. However, its long half-life and unique pharmacokinetics make it challenging to compare directly to other opioids.

Weaker Opioids: Managing Mild to Moderate Pain

At the lower end of the opioid potency scale, we find medications that are often used for mild to moderate pain. While these opioids are considered “weaker,” they can still be effective pain relievers and carry risks of dependence and side effects.

Codeine

Codeine is approximately 0.13 times as potent as morphine. It’s often used for mild to moderate pain and is frequently combined with non-opioid pain relievers like acetaminophen.

Tramadol

Tramadol has a potency of about 0.1-0.2 times that of morphine. It’s considered a weak opioid agonist and also has effects on serotonin and norepinephrine reuptake, contributing to its pain-relieving properties.

Propoxyphene

While no longer available in many countries due to safety concerns, propoxyphene was once widely used for mild to moderate pain. Its potency is similar to or slightly less than codeine.

The Importance of Opioid Equivalence in Clinical Practice

Understanding opioid equivalence is crucial for healthcare providers when managing patients’ pain or transitioning between different opioid medications. This knowledge helps in several key areas:

1. Dose Conversion: When switching from one opioid to another, equivalence charts help determine appropriate dosing to maintain pain control while minimizing risks.
2. Risk Assessment: Recognizing the relative potencies of different opioids aids in assessing the potential for adverse effects or overdose.
3. Individualized Treatment: Patients may respond differently to various opioids, and understanding equivalence allows for more personalized pain management strategies.
4. Harm Reduction: In the context of opioid misuse and addiction, knowledge of relative potencies can inform safer tapering protocols and medication-assisted treatment approaches.

However, it’s crucial to note that opioid equivalence charts provide general guidelines and should not be used as rigid rules. Individual patient factors, including age, kidney function, and concurrent medications, can significantly impact opioid metabolism and effects.

Challenges in Comparing Opioid Potencies

While opioid equivalence charts provide valuable guidance, several factors complicate direct comparisons between different opioids:

Incomplete Cross-Tolerance

Patients who develop tolerance to one opioid may not have complete cross-tolerance to another. This means that when switching between opioids, the calculated equivalent dose may be too high, potentially leading to adverse effects.

Individual Variability

Genetic differences in opioid metabolism can lead to significant variations in how individuals respond to different opioids. For example, some people may be poor metabolizers of codeine, rendering it less effective for pain relief.

Multimodal Mechanisms

Some opioids, like tramadol and tapentadol, have additional mechanisms of action beyond pure mu-opioid receptor activation. This can make direct potency comparisons more challenging.

Route of Administration Effects

The relative potencies of opioids can change depending on the route of administration. For instance, the oral-to-intravenous potency ratio may differ between opioids.

Given these complexities, healthcare providers must approach opioid conversions cautiously, often starting with lower doses than calculated and titrating based on individual patient response.

The Role of Opioid Potency in Overdose Risk

Understanding the relative potencies of different opioids is crucial in assessing and mitigating overdose risks. Higher potency opioids generally carry a greater risk of overdose, particularly when misused or when tolerance is misjudged.

Fentanyl and Its Analogs

The extreme potency of fentanyl and its analogs has contributed significantly to the opioid overdose crisis. Even small errors in dosing or the presence of fentanyl in other illicit drugs can lead to fatal overdoses.

Prescription Opioid Risks

Even among prescription opioids, variations in potency contribute to overdose risks. For example, patients accustomed to lower-potency opioids like codeine may be at higher risk if transitioned too quickly to more potent options like oxycodone or hydromorphone.

Harm Reduction Strategies

Knowledge of opioid potencies informs harm reduction strategies, such as:

• Naloxone distribution programs targeting high-potency opioid users
• Education on the dangers of mixing opioids with other central nervous system depressants
• Fentanyl test strip programs to detect the presence of high-potency opioids in drug supplies

Healthcare providers and public health officials must continue to emphasize the importance of understanding opioid potencies in both clinical practice and harm reduction efforts.

Future Directions in Opioid Potency Research

As our understanding of opioid pharmacology continues to evolve, several areas of research hold promise for refining our approach to opioid potency and pain management:

Personalized Medicine Approaches

Advances in pharmacogenomics may allow for more personalized opioid prescribing based on individual genetic profiles. This could lead to more accurate predictions of opioid potency and effectiveness for each patient.

Novel Opioid Formulations

Research into new opioid formulations aims to maintain analgesic efficacy while reducing risks. This includes developing opioids with lower abuse potential or formulations that limit the risk of respiratory depression.

Alternative Pain Management Strategies

As concerns about opioid risks continue, research into non-opioid and multimodal pain management approaches is intensifying. This may lead to reduced reliance on high-potency opioids for certain pain conditions.

Improved Understanding of Opioid Receptor Dynamics

Ongoing research into the complex interactions between opioids and their receptors may provide new insights into potency differences and guide the development of more targeted pain medications.

As research progresses, our understanding of opioid potency and its clinical implications will continue to evolve, potentially leading to safer and more effective pain management strategies.

Table A6.2, Approximate potency of opioids relative to morphine; PO and immediate-release formulations unless stated otherwisea – WHO Guidelines for the Pharmacological and Radiotherapeutic Management of Cancer Pain in Adults and Adolescents

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

WHO Guidelines for the Pharmacological and Radiotherapeutic Management of Cancer Pain in Adults and Adolescents. Geneva: World Health Organization; 2018.

WHO Guidelines for the Pharmacological and Radiotherapeutic Management of Cancer Pain in Adults and Adolescents.

Show details

• Contents

Search term

Table A6.2Approximate potency of opioids relative to morphine; PO and immediate-release formulations unless stated otherwise

^a

Source: Adapted with permission from Twycross et al. 2017:371 (Table 4) (3).

a

Multiply dose of opioid in the first column by relative potency in the second column to determine the equivalent dose of morphine sulfate/hydrochloride; conversely, divide morphine dose by the relative potency to determine the equivalent dose of another opioid.

b

Dependent in part on severity of pain and on dose; often longer-lasting in very elderly and those with renal impairment.

c

The numbers in parenthesis are the manufacturers’ preferred relative potencies.

d

A single 5 mg dose of methadone is equivalent to morphine 7.5 mg, but a variable long plasma half-life and broad-spectrum receptor affinity result in a much higher-than-expected relative potency when administered regularly – sometimes much higher than the range given above. Therefore, guidance from a specialist is recommended for conversions to regularly administered methadone.

From: ANNEX 6, Pharmacological Profiles and Opioid Conversion Tables

© World Health Organization 2018.

Sales, rights and licensing. To purchase WHO publications, see http://apps.who.int/bookorders. To submit requests for commercial use and queries on rights and licensing, see http://www.who.int/about/licensing.

Third-party materials. If you wish to reuse material from this work that is attributed to a third party, such as tables, figures or images, it is your responsibility to determine whether permission is needed for that reuse and to obtain permission from the copyright holder. The risk of claims resulting from infringement of any third-party-owned component in the work rests solely with the user.

Some rights reserved. This work is available under the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 IGO licence (CC BY-NC-SA 3.0 IGO; https://creativecommons.org/licenses/by-nc-sa/3.0/igo).

Under the terms of this licence, you may copy, redistribute and adapt the work for non-commercial purposes, provided the work is appropriately cited, as indicated below. In any use of this work, there should be no suggestion that WHO endorses any specific organization, products or services. The use of the WHO logo is not permitted. If you adapt the work, then you must license your work under the same or equivalent Creative Commons licence. If you create a translation of this work, you should add the following disclaimer along with the suggested citation: “This translation was not created by the World Health Organization (WHO). WHO is not responsible for the content or accuracy of this translation. The original English edition shall be the binding and authentic edition”.

Any mediation relating to disputes arising under the licence shall be conducted in accordance with the mediation rules of the World Intellectual Property Organization.

Contents

• Cite this Page
• PDF version of this title (1.2M)
• Disable Glossary Links

Other titles in this collection

• WHO Guidelines Approved by the Guidelines Review Committee

Recent Activity

ClearTurn OffTurn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more…

Discover the List of Opioids From Strongest to Weakest to Avoid Overdose Updated 2023

September 11, 2017
by Mark Adams

A Guide to Addictive Opiates: List of Opioids Strongest to Weakest

Post updated 3-10-2023

Creating a list of opioids from strongest to weakest is not as straightforward as simply listing them by potency or by an analgesic effect. A report released by the CDC (1) listed various narcotic pain medications by strength as they compared to morphine. Yet the list doesn’t determine whether the medication also has a similar mechanism of action. Some of the strongest types of pain medication in a hospital may have a similar potency to morphine, but they may also be formulated with a dose ceiling, while morphine does not, rendering them less potent overall.  

The actual potency of some narcotic pain medications and prescription opioids, or pain relievers by strength, may also vary, depending on the route of administration.  Essentially, the list of opioids strongest to weakest is determined by factoring in that a smaller dose of certain painkiller medications may be required to achieve the same pain-relief response to treat severe pain as can be reached with morphine.

With those determinations in mind, the list of common opioids from strongest to weakest is also broken down into three classifications: stronger than morphine, morphine-equivalent and weaker than morphine.

Stronger than Morphine

Opioid use disorders (OUD) are on the rise. Let’s take a look at some of the drugs that are stronger than morphine.

Fentanyl (Duragesic)

 Fentanyl is common among drug abusers and is one of the strongest opioids on the market and is the strongest pain medication in hospital settings. This drug can lead to abuse and addiction. The opioid painkiller medication has a rapid onset and short duration of action. It’s occasionally used as a part of the anesthesia process to help prevent pain following surgery but it is also used to treat severe pain. Depending on the method of administration, it’s estimated that fentanyl can be up to 100 times more potent than morphine and is classified as one of the strongest opioids.

Oxymorphone (Opana ER, Numorphan)

Oxymorphone is a semi-synthetic opioid painkiller medication commonly used to treat severe to chronic pain and to maintain anesthesia. The powerful opioid medication is highly addictive and requires an opioid addiction treatment program to overcome, leading the FDA to ask the manufacturer to remove it from the US market in 2017.

Hydromorphone (Dilaudid, Exalgo, Contin)

Hydromorphone is synthesized from morphine and is commonly used in hospital settings to treat moderate to severe pain. The medication is more soluble in water than morphine, which allows the drug to be delivered in a smaller amount of water.

Heroin (diamorphine)

Heroin is created by combining the morphine alkaloid with acetic anhydride to create a more potent opioid analgesic drug. While heroin was once used in medical settings, it was made a Schedule I Substance under the Controlled Substances Act in 1924 and is now an illicit drug used primarily for recreational purposes. It’s estimated that heroin is approximately 2 to 4 times more potent than morphine. Heroin addiction is a contributing factor to the drug epidemic that the U.S. is facing and is leading to mass overdose deaths. 

Levorphanol (Levo-Dromoran)

Levorphanol is a synthetic opioid painkiller medication created from the compound racemorphan and used to treat moderate to severe pain. Levorphanol is produced using one of the two enantiomers of the compound racemorphan. Levorphanol is several times more potent than morphine and is strongly addicting.

Methadone (Dolophine, Methadone)

Methadone is an opioid painkiller medication used to treat moderate to severe pain. It’s also prescribed to treat opioid dependence in methadone maintenance programs.  It is considered more potent than morphine due to its effectiveness against neuropathic pain. There is also a lower risk of the user developing dose tolerance with methadone (2) as compared to other types of opioids.

Oxycodone (OxyContin, Roxicodone)

Oxycodone has a greater analgesic effect than morphine (6). The semi-synthetic opioid is synthesized from thebaine, an alkaloid found in the opium poppy and is approximately 1.5 times stronger than morphine.

Morphine-Equivalent

Tapentadol (Nucynta, Palexia SR): Technically, tapentadol could be classified as stronger than morphine, as clinical trials (3) indicate the medication provides superior analgesic effects than equivalent doses of oxycodone, but with significantly lower gastrointestinal side effects. However, as tapentadol has a dose ceiling, so it’s listed as a morphine-equivalent ahead in order of strength to morphine.

Morphine (Astramorph, Avinza, Kadian)

Morphine is created from the morphine alkaloid found within the opium poppy and is commonly used to treat moderate to severe pain. Approximately 70% of morphine produced is used as a base to create other opioid medications (5), including oxymorphone, hydromorphone, and heroin.

Hydrocodone (Zohydro ER)

Hydrocodone is a semi-synthetic opiate analgesic created from the codeine alkaloid found within the opium poppy.  Hydrocodone is commonly used to treat moderate to severe pain and is predominantly used within the United States, with 99% of the world’s volume of hydrocodone consumed in that country. Hydrocodone is also commonly available in a variety of formulations, including combinations with paracetamol (Vicodin), ibuprofen (Vicoprofen), or aspirin (Lortab).

Weaker Than Morphine

Pethidine (Meperidine, Demerol)

Pethidine is a synthetic opioid painkiller medication and is usually prescribed to treat moderate to severe pain. While it provides almost equivalent levels of pain relief to morphine in treating post-surgical pain, the method of administration may differ and the dosage used may need to be slightly higher than the comparative dose of morphine to achieve similar results (4).

Codeine

Codeine is created from the codeine alkaloid found within the opium poppy that is commonly used to treat mild to moderate pain. Codeine’s efficacy comes from the drug being broken down in the liver into morphine. Codeine is the most commonly taken opiate medication in the world (5).

Tramadol (Ultram)

Tramadol is an opiate painkiller medication used to treat moderate pain. The medication is synthesized as a racemic mixture using both components of R- and S-stereoisomers.

Laudanum (Opium Tincture)

Of the list of opioids strongest to weakest, the least potent opiate is still available from some pharmacies in the US and UK. The formulation is used primarily to control diarrhea or to ease withdrawal symptoms in babies born to opiate-addicted mothers. In the 1800s morphine was known as laudanum and was readily available from grocers and markets, but was soon restricted once its addictive qualities were known. Today, laudanum is sold as a ‘tincture of opium,’ which contains approximately 10% (100mg) powdered opium, or the equivalent of 1% (10mg) morphine per milliliter. The tincture is considered a single formulation, as it contains all of the alkaloids found within the opium poppy.

WhiteSands Treatment Center offers all levels of care to those struggling with drug addiction and opioid drugs. Through substance abuse treatment programs, patients can regain control of their lives and learn to manage their addiction.